NCT01527942

Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients

Effect of Intravenous Acetaminophen on Postoperative Pain of Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized, Placebo-Controlled Trial

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 34 (actual)
• Sponsor: Trinity Health Of New England · Academic / Other
• Sex: All
• Age: 20 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Bariatric patients usually require the use of either intravenous or oral opioid medications. The use of opioids, however, is often associated with side-effects such as nausea, sedation pruritus, urinary retention and respiratory depression with often delay patient discharge. This study makes use of intravenous acetaminophen , a non-opioid analgesic preoperatively to determine if this will decrease the use of opioids post-operatively for pain management in morbidly obese patients undergoing laparoscopic bariatric surgery.

Conditions

• Obesity
• Pain

Interventions

Type	Name	Description
DRUG	Acetaminophen	Intravenous Acetaminophen 1,000 mg IV
DRUG	Placebo	Placebo - IV administration 0.9% 100 ml Sodium Chloride (NaCl)

Timeline

• Start date: 2012-03-01
• Primary completion: 2013-07-01
• Completion: 2013-07-01
• First posted: 2012-02-07
• Last updated: 2015-12-17
• Results posted: 2015-12-17

Locations

1 site across 1 country: United States